Global Thrombectomy Devices Market to expand with 5.9% CAGR through 2027

December 06, 2019


According to the research report titled ‘Thrombectomy Devices Market to 2027 - Global Analysis and Forecasts by Type (Mechanical Thrombectomy Devices, Aspiration Thrombectomy, Devices, Rheolytic Thrombectomy Devices and Ultrasonic Thrombectomy), Application (Cardiovascular, Peripheral Vascular, Neurovascular), End User (Academic & Research Institutes, Hospitals & Clinics, Ambulatory Surgical Center) and Geography’ available at MarketStudyReport.com, the global thrombectomy devices market was reckoned to be at US $1,282.07 million in 2018 and is estimated to grow with a CAGR of 5.9% over the analysis timeline and account for US $2,101.29 million by the year 2027.
 

For the record, thrombectomy is a type of surgery conducted to remove any blood clot from a vein or an artery. During the surgery, thrombectomy devices are used to make an opening in the blood vessel to remove the clot which in turns repairs the blood flow.
 

Growing occurrences of neurological disorders and cardiovascular diseases across the globe, coupled with advancements in medical technologies, and favorable healthcare reimbursement conditions are major factors driving the growth of the global thrombectomy devices market for the forecast period. Increasing focus and investment towards research and study in thrombectomy field is also aiding the market growth. 
 

Based on type, thrombectomy devices market is categorized into aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices, and rheolytic thrombectomy devices. According to the report, mechanical thrombectomy devices market held the largest share in 2018, owing to growing adoption of these devices for surgeries such as pulmonary embolism (PE), venous thromboembolism (VTE), deep vein thrombosis (DVT), and acute stroke.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2337544/
 

As per application, thrombectomy devices market is classified into peripheral vascular, cardiovascular, and neurovascular, whereas on the basis of end user spectrum, the industry is bifurcated into hospitals & clinics, academic & research institutes, and ambulatory surgical centers.
 

The key players operating in thrombectomy devices industry are Koninklijke Philips N.V., Penumbra, Inc., Teleflex Incorporated, Edwards Lifesciences Corporation, Medtronic, Johnson & Johnson Services, Inc., Inari Medical, ARGON MEDICAL, Terumo Corporation, and Stryker Corporation.


Frequently Asked Questions (FAQ) :

Growing occurrences of neurological disorders and cardiovascular diseases across the globe, coupled with advancements in medical technologies and favorable healthcare reimbursement conditions are major factors driving the growth of the global thrombectomy devices market for the forecast period. Increasing focus and investment towards research and study in thrombectomy field is also aiding the market growth.
The global thrombectomy devices market was reckoned to be at US $1,282.07 million in 2018 and is estimated to grow with a CAGR of 5.9% over the analysis period and account for US $2,101.29 million by 2027.
Based on type, thrombectomy devices market is categorized into aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices and rheolytic thrombectomy devices. According to the report, mechanical thrombectomy devices market held the largest share in 2018, owing to growing adoption of these devices for surgeries such as pulmonary embolism (PE), venous thromboembolism (VTE), deep vein thrombosis (DVT), and acute stroke.
The key players operating in thrombectomy devices industry are Koninklijke Philips N.V., Penumbra, Inc., Teleflex Incorporated, Edwards Lifesciences Corporation, Medtronic, Johnson & Johnson Services, Inc., Inari Medical, ARGON MEDICAL, Terumo Corporation, and Stryker Corporation.